Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 4;13(4):621. doi: 10.3390/cancers13040621

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

S100A7 correlates with adverse clinico-pathological features in ER-positive breast cancer patients. (A) Box plot depicting the differential expression of S100A7 in ER-positive and ER-negative BC patients as found in the METABRIC cohort; (****) p < 0.0001. (B) S100A7 expression correlates with a worse overall survival of ER-positive BC patients in the METABRIC cohort. (C) The expression levels of S100A7 were higher in ER-positive BC patients with more advanced tumor grade. (****) p < 0.0001; the number of patients of each group is indicated in the figure.